Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
30 participants
OBSERVATIONAL
2024-12-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Can detailed sagittal height measurements obtained from the Oculus Pentacam Corneal Scleral Profile (CSP) predict the necessary adjustments for optimal scleral lens fit? Will the use of these measurements reduce the number of trial-and-error adjustments needed to achieve an ideal fit, thereby reducing chair time and improving patient satisfaction?
Participants will:
Undergo detailed corneal and scleral tomography using the Oculus Pentacam with the CSP strategy.
Receive customized ICD 16.5 mm scleral lenses based on precise measurements of their ocular surface.
Participate in follow-up assessments to evaluate the fit of the lenses and provide feedback on comfort and visual outcomes.
This study focuses on a specific participant population of adults aged 18 and older who have not had success with other types of contact lenses. By leveraging advanced imaging technologies, the research aims to streamline the fitting process for scleral lenses, potentially setting new standards for treatment efficacy in specialty contact lens practices.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Objectives:
The primary objective of the study is to determine if detailed sagittal height measurements obtained from the Oculus Pentacam CSP can predict the necessary adjustments required for an optimal scleral lens fit. The secondary objective is to assess whether the use of these precise measurements can reduce the number of adjustments and follow-up visits typically required, thus improving overall patient satisfaction and clinical efficiency.
Methods and Procedures:
Participants will be enrolled based on specific inclusion criteria, including a history of intolerance or incompatibility with other forms of contact lenses. The study will include the following steps:
Initial Evaluation: Comprehensive ocular surface assessment using the Oculus Pentacam, which provides detailed corneal and scleral topography.
Lens Fitting: Custom scleral lenses will be fitted based on the Pentacam CSP measurements, with a focus on achieving a central vault of approximately 300 microns over the cornea.
Follow-Up Assessments: Participants will return for follow-up visits to assess the fit of the lenses, comfort, and visual outcomes. Adjustments to the lenses will be made based on these assessments.
Imaging and Technology:
The Oculus Pentacam CSP is a pivotal tool in this study, offering high-resolution imaging that captures detailed topographical data of both the cornea and sclera. This data is crucial for customizing each scleral lens to the unique contours of the patient's ocular surface, potentially reducing the iterative nature of traditional scleral lens fittings.
Expected Outcomes:
The study is expected to produce several key outcomes:
Validation of Predictive Models: Establishing reliable predictive models correlating sagittal height measurements with lens fitting parameters.
Clinical Efficiency: Reduction in the total number of fitting sessions required, as well as decreased chair time during each visit.
Patient Satisfaction: Improvement in patient comfort and visual acuity, leading to higher satisfaction rates.
Impact on Clinical Practice:
By demonstrating the effectiveness of integrating advanced imaging technologies into the scleral lens fitting process, this study aims to influence current practices significantly. It is anticipated that the results will provide evidence-based guidelines that can be adopted widely, leading to more predictable and efficient scleral lens fittings across various clinical settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: Advanced ICD Fitting with Pentacam CSP
This cohort involves a single group of patients who will undergo an innovative scleral lens fitting process using the Oculus Pentacam Corneal Scleral Profile (CSP) analysis. The intervention focuses on enhancing the precision and predictability of ICD scleral lens adaptations by utilizing advanced imaging techniques to measure corneal and scleral topography. Participants will receive custom-fitted ICD scleral lenses designed based on detailed ocular surface measurements captured by Pentacam CSP. The main goal is to achieve optimal fitting with reduced chair time and fewer adjustment visits.
The Pentacam CSP provides high-resolution, three-dimensional scans of the anterior segment, allowing for precise mapping of both the cornea and sclera. This data is crucial for determining the appropriate sagittal depth and lens curvature needed for each patient, aiming to enhance comfort and visual outcomes. By integrating these measurements, the study seeks to develop a more efficient and effect
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Previous intolerance or inability to use other types of contact lenses such as soft or rigid gas-permeable lenses.
Willing and able to comply with scheduled visits, treatment plan, and other study procedures.
Adequate ocular health suitable for contact lens wear, except for conditions being treated in the study.
Ability to give informed consent.
Exclusion Criteria
Any condition which, in the opinion of the investigator, may interfere with safe participation in the study or adherence to study procedures.
Participation in another simultaneous clinical trial that might confound the results of the current study.
Pregnant or breastfeeding women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro de Miopía Fernández-Velázquez
NETWORK
Fernando Fernandez Velazquez
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fernando Fernandez Velazquez
Doctor of Optometry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Miopia Fernandez-Velazquez
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMFV-SCL-2024-03
Identifier Type: -
Identifier Source: org_study_id